Thomas B. Hartman

President & CEO

Tom Hartman is the newly appointed CEO and President of ISPE, beginning in this role on 1 June 2020. He most recently served as the Vice President of GMP Operations, Biopharm CMC, for GlaxoSmithKline, with responsibility for the biopharmaceutical API and Drug Product supply chain including cell banks, raw materials, manufacturing operations, eng...


Roles at ISPE

  • President & CEO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.